Primary Generalized tonic-clonic seizure

Also known as: Primary generalized tonic-clonic seizures / Seizures, Tonic-Clonic / Generalised tonic-clonic seizure / Generalized Tonic Clonic Seizures / Seizure grand mal / Generalized tonic clonic seizure / Generalised tonic-clonic seizures / Tonic-clonic Seizure / Grand mal Seizures / Centrencephalic epilepsies / Generalized tonic-clonic Seizure / Grand mal Generalized tonic-clonic seizure / Generalized Tonic-Clonic Seizures / Grand mal seizure / Grand mal epileptic seizure / Tonic-clonic seizures / Centrencephalic epilepsy / Other generalized epilepsy and epileptic syndromes / Generalised onset motor seizure / Generalized onset motor seizure / Grand mal seizure (finding) / Tonic-clonic seizure (finding) / Grand mal fit / Grand mal epileptic fit / Centrencephalic epilepsy (disorder)

DrugDrug NameDrug Description
DB06218LacosamideAn antiepileptic drug used to treat partial-onset seizures and primary generalized tonic-clonic seizures.
DB00555LamotrigineA phenyltriazine antiepileptic used to treat some types of epilepsy and bipolar I disorder.
DB01202LevetiracetamA novel anticonvulsant agent used as an adjunct medication to manage partial onset, myoclonic, and generalized tonic-clonic seizures in patients with epilepsy.
DrugDrug NameTargetType
DB06218LacosamideSodium channel protein type 9 subunit alphatarget
DB06218LacosamideSodium channel protein type 3 subunit alphatarget
DB06218LacosamideSodium channel protein type 10 subunit alphatarget
DB06218LacosamideCytochrome P450 2C19enzyme
DB06218LacosamideCytochrome P450 2C9enzyme
DB06218LacosamideCytochrome P450 3A4enzyme
DB00555LamotrigineVoltage-gated sodium channel alpha subunittarget
DB00555LamotrigineUDP-glucuronosyltransferases (UGTs)enzyme
DB00555LamotrigineP-glycoprotein 1transporter
DB00555LamotrigineDihydrofolate reductaseenzyme
DB00555Lamotrigine5-hydroxytryptamine receptor 3Atarget
DB00555LamotrigineVoltage-dependent R-type calcium channel subunit alpha-1E (CACNA1E)target
DB00555LamotrigineAdenosine receptor A1target
DB00555LamotrigineAdenosine receptor A2atarget
DB00555LamotrigineAlpha-1A adrenergic receptortarget
DB00555LamotrigineAlpha-2A adrenergic receptortarget
DB00555LamotrigineBeta-1 adrenergic receptortarget
DB00555LamotrigineD(1) dopamine receptortarget
DB00555LamotrigineDopamine D2 receptortarget
DB00555LamotrigineGABA(A) Receptortarget
DB00555LamotrigineGABA(A) Receptor Benzodiazepine Binding Sitetarget
DB00555LamotrigineHistamine H1 receptortarget
DB00555LamotrigineKappa-type opioid receptortarget
DB00555LamotrigineAcetylcholine receptor subunit alphatarget
DB00555Lamotrigine5-hydroxytryptamine receptor 2Atarget
DB00555LamotrigineSolute carrier family 22 member 2transporter
DB00555LamotrigineSerum albumincarrier
DB00555LamotrigineSolute carrier family 22 member 1transporter
DB00555LamotrigineGlutamate receptor 1target
DB01202LevetiracetamSynaptic vesicle glycoprotein 2Atarget
DB01202LevetiracetamP-glycoprotein 1transporter
DB01202LevetiracetamVoltage-dependent N-type calcium channel subunit alpha-1Btarget
DrugDrug NamePhaseStatusCount
DB08883Perampanel4Completed1
DB08883PerampanelNot AvailableCompleted2